GSE80098,GSE80366 0 V 4 PROGESTERONE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE80098,GSE80366 0 V 4 PROGESTERONE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE80098,GSE80366 0 V 4 PROGESTERONE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE80098,GSE80366 0 V 4 PROGESTERONE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE80098,GSE80366 0 V 4 PROGESTERONE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

interferon lambda 4 (gene/pseudogene)

Gene

dynein axonemal light intermediate chain 1

Gene

cystathionine beta-synthase like

Gene

UBX domain protein 11

Gene

protocadherin alpha 1

Gene

CDK5 regulatory subunit associated protein 2

Gene

calcium modulating ligand

Gene

striatin interacting protein 2

Gene

keratin 75

  • Gene

    Rho GTPase activating protein 23


  • Gene

    interferon lambda 4 (gene/pseudogene)


  • Gene

    dynein axonemal light intermediate chain 1


  • Gene

    cystathionine beta-synthase like


  • Gene

    UBX domain protein 11


  • Gene

    protocadherin alpha 1


  • Gene

    CDK5 regulatory subunit associated protein 2


  • Gene

    calcium modulating ligand


  • Gene

    striatin interacting protein 2


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.